BlackRock’s Sensei Biotherapeutics SNSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-389
| Closed | -$4.82K | – | 5242 |
|
|
2024
Q2 | $4.82K | Sell |
389
-1,290
| -77% | -$16K | ﹤0.01% | 5077 |
|
|
2024
Q1 | $35.3K | Sell |
1,679
-62
| -4% | -$1.3K | ﹤0.01% | 4881 |
|
|
2023
Q4 | $24.1K | Sell |
1,741
-20
| -1% | -$277 | ﹤0.01% | 4988 |
|
|
2023
Q3 | $28.2K | Sell |
1,761
-72
| -4% | -$1.15K | ﹤0.01% | 5027 |
|
|
2023
Q2 | $41.8K | Sell |
1,833
-72
| -4% | -$1.64K | ﹤0.01% | 5008 |
|
|
2023
Q1 | $57.2K | Buy |
1,905
+61
| +3% | +$1.83K | ﹤0.01% | 5010 |
|
|
2022
Q4 | $54.9K | Sell |
1,844
-6,854
| -79% | -$204K | ﹤0.01% | 5118 |
|
|
2022
Q3 | $270K | Sell |
8,698
-247
| -3% | -$7.67K | ﹤0.01% | 4806 |
|
|
2022
Q2 | $406K | Sell |
8,945
-49,456
| -85% | -$2.24M | ﹤0.01% | 4750 |
|
|
2022
Q1 | $2.7M | Sell |
58,401
-1,735
| -3% | -$80.1K | ﹤0.01% | 4185 |
|
|
2021
Q4 | $6.98M | Buy |
60,136
+10,120
| +20% | +$1.17M | ﹤0.01% | 3790 |
|
|
2021
Q3 | $10.5M | Buy |
50,016
+31,843
| +175% | +$6.7M | ﹤0.01% | 3593 |
|
|
2021
Q2 | $3.55M | Buy |
18,173
+1,538
| +9% | +$300K | ﹤0.01% | 3958 |
|
|
2021
Q1 | $4.83M | Buy |
+16,635
| New | +$4.83M | ﹤0.01% | 3895 |
|